
Join to View Full Profile
3161 Elliott AvenueSuite 200Seattle, WA 98121
Dr. Hudson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Chad Hudson, MD, PhD, is a Seattle-based clinical pathologist specializing in flow cytometric-based MRT. He graduated from SUNY Upstate Medical University in 2010 and completed his residency in anatomic and clinical pathology at the University of Rochester between 2012 and 2016. Dr. Hudson has been actively involved in research, with multiple publications to his name, including articles in Blood, Journal of Clinical Oncology, Haematologica, Methods in Cell Biology, and Cytometry. His research primarily focuses on leukemia, with several of his studies cited by other publications.
Education & Training
- University of RochesterResidency, Pathology-Anatomic and Clinical, 2012 - 2016
- SUNY Upstate Medical UniversityClass of 2010
Certifications & Licensure
- WA State Medical License 2019 - 2026
- NY State Medical License 2018 - 2025
- American Board of Pathology Pathology - Clinical
Publications & Presentations
PubMed
- 2 citationsCD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children's Oncology Group.Andrew J Menssen, Chad A Hudson, Todd Alonzo, Robert Gerbing, Laura Pardo
Haematologica. 2024-10-01 - 2 citationsFusion-harboring mast cells can explain molecular positivity in flow cytometric MRD-negative core-binding factor AML.Jacqueline A Cook, Loren Lott, Jenna Perry, Ashley M Eckel, Dongbin Xu
Blood. 2024-08-01 - 4 citationsBosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921.Erica Brivio, Edoardo Pennesi, Marieke E Willemse, Alwin D R Huitema, Yilin Jiang
Journal of Clinical Oncology. 2024-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: